Greg Grabowski

Dr. Grabowski is a leading authority in genetic diseases and metabolic disorders. He is the former Director of Human Genetics (DHG) at the Cincinnati Children's Hospital Medical Center (CCHMC) as well as Professor in the Departments of Molecular Genetics, Biochemistry, and Microbiology, and Pediatrics, at the University of Cincinnati College of Medicine. In 2014, after over twenty years at CCHMC, Dr. Grabowski joined Synageva BioPharma as Chief Scientific Officer to continue the pursuit of therapies for rare, devastating, inherited diseases. From 2015-2019, he held the same position at Kiniksa Pharmaceuticals, Ltd. Currently, he is Professor Emeritus in the above Departments, and is a Consultant for and/or member of Scientific Advisory Boards for several rare disease biotech companies and Foundations, including the Silverstein Foundation and the Michael J. Fox Foundation.